TEX50
gene geneOn this page
Summary
TEX50 (testis expressed 50, HGNC:52382) is a protein-coding gene on chromosome 1q25.1, encoding Testis-expressed protein 50 (A0A1B0GTY4). Sperm membrane protein required for stability of the sperm acrosome after its formation in the testis.
Predicted to be located in membrane.
Source: NCBI Gene 730159 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001195190
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:52382 |
| Approved symbol | TEX50 |
| Name | testis expressed 50 |
| Location | 1q25.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000232113 |
| Ensembl biotype | protein_coding |
| OMIM | 621346 |
| Entrez | 730159 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000417563
RefSeq mRNA: 1 — MANE Select: NM_001195190
NM_001195190
CCDS: CCDS81405
Canonical transcript exons
ENST00000417563 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001740983 | 173635338 | 173635845 |
| ENSE00001781248 | 173636827 | 173637130 |
Expression profiles
Bgee: expression breadth tissue_specific, 9 present calls, max score 91.89.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0109 / max 9.9239, expressed in 3 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 6731 | 0.0063 | 3 |
| 6732 | 0.0046 | 3 |
Top tissues by expression
123 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.89 | gold quality |
| right testis | UBERON:0004534 | 86.05 | gold quality |
| left testis | UBERON:0004533 | 85.20 | gold quality |
| testis | UBERON:0000473 | 84.75 | gold quality |
| cerebellar vermis | UBERON:0004720 | 76.33 | gold quality |
| thymus | UBERON:0002370 | 58.17 | silver quality |
| corpus callosum | UBERON:0002336 | 43.04 | gold quality |
| granulocyte | CL:0000094 | 38.92 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| mucosa of stomach | UBERON:0001199 | 35.19 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.66 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 32.00 | gold quality |
| muscle tissue | UBERON:0002385 | 31.29 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| liver | UBERON:0002107 | 29.94 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| leukocyte | CL:0000738 | 28.71 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| monocyte | CL:0000576 | 28.12 | silver quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 27.80 | silver quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| blood | UBERON:0000178 | 26.48 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.14 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tex50 | ENSMUSG00000049160 |
| rattus_norvegicus | Tex50 | ENSRNOG00000038786 |
Protein
Protein identifiers
Testis-expressed protein 50 — A0A1B0GTY4 (reviewed: A0A1B0GTY4)
All UniProt accessions (1): A0A1B0GTY4
UniProt curated annotations — full annotation on UniProt →
Function. Sperm membrane protein required for stability of the sperm acrosome after its formation in the testis. Essential for male fertility.
Subcellular location. Membrane.
Tissue specificity. Testis-specific.
RefSeq proteins (1): NP_001182119* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR038833 | TEX50 | Family |
UniProt features (5 total): signal peptide 1, chain 1, transmembrane region 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1B0GTY4-F1 | 65.84 | 0.13 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 2 (showing top):
chr1q25, MAFG_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
36 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TEX50 | ZBTB37 | Q5TC79 | 643 |
| TEX50 | ANKRD45 | Q5TZF3 | 633 |
| TEX50 | KIAA0040 | Q15053 | 585 |
| TEX50 | SLC9C2 | Q5TAH2 | 561 |
| TEX50 | PIGC | Q92535 | 476 |
| TEX50 | KLHL20 | Q9Y2M5 | 443 |
| TEX50 | DARS2 | Q6PI48 | 435 |
| TEX50 | CENPL | Q8N0S6 | 419 |
| TEX50 | SUCO | Q9UBS9 | 408 |
| TEX50 | CACYBP | Q9HB71 | 392 |
| TEX50 | RC3H1 | Q5TC82 | 391 |
| TEX50 | DNM3 | Q9UQ16 | 337 |
| TEX50 | TNFSF18 | Q9UNG2 | 310 |
| TEX50 | PRDX6 | P30041 | 270 |
| TEX50 | TNFSF4 | P23510 | 229 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GTR0, A0A1B0GTY4, A0A1B0GVD1, A7WNB0, A8R0V4, E9Q7F5, O55779, O70552, O75818, O93036, P01586, P03212, P03319, P03321, P04823, P0DOE0, P10260, P13206, P16837, P20880, P28907, P36340, P47939, P47940, Q02484, Q03233, Q1HVF6, Q2HRD2, Q3KSS3, Q3TTJ4, Q5BK38, Q5QR91, Q5VAN0, Q64277, Q66669, Q66672, Q6GQU0, Q6GVM5, Q6UWF9, Q86WR6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
118 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:173635537:C:CT | donor_gain | 0.9500 |
| 1:173635538:T:TT | donor_gain | 0.9500 |
| 1:173635536:A:AC | donor_gain | 0.8900 |
| 1:173635565:T:C | donor_gain | 0.7900 |
| 1:173635540:CCG:C | donor_gain | 0.7500 |
| 1:173635541:CGC:C | donor_gain | 0.7100 |
| 1:173636104:C:CT | donor_gain | 0.7100 |
| 1:173636105:T:TT | donor_gain | 0.7100 |
| 1:173635679:ACTG:A | donor_gain | 0.6100 |
| 1:173635680:CTGC:C | donor_gain | 0.6100 |
| 1:173635767:A:AC | acceptor_gain | 0.6100 |
| 1:173635692:T:C | donor_gain | 0.5700 |
| 1:173636138:T:C | donor_gain | 0.5600 |
| 1:173635682:G:GA | donor_gain | 0.5300 |
| 1:173635833:ACACC:A | acceptor_gain | 0.5200 |
| 1:173635539:A:AA | donor_gain | 0.5000 |
| 1:173635686:G:A | donor_gain | 0.5000 |
| 1:173635771:CAAG:C | acceptor_gain | 0.4900 |
| 1:173635835:ACC:A | acceptor_gain | 0.4900 |
| 1:173635824:ATGG:A | acceptor_gain | 0.4800 |
| 1:173635791:A:C | acceptor_gain | 0.4700 |
| 1:173635823:AATGG:A | acceptor_gain | 0.4700 |
| 1:173635679:A:AC | donor_gain | 0.4400 |
| 1:173635680:C:CC | donor_gain | 0.4400 |
| 1:173635790:T:TC | acceptor_gain | 0.4300 |
| 1:173635836:CC:C | acceptor_gain | 0.4100 |
| 1:173635834:CACC:C | acceptor_gain | 0.4000 |
| 1:173635635:T:TA | donor_gain | 0.3900 |
| 1:173635797:T:TG | acceptor_gain | 0.3900 |
| 1:173635837:C:A | acceptor_gain | 0.3900 |
AlphaMissense
1170 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:173635609:T:A | W30R | 0.932 |
| 1:173635609:T:C | W30R | 0.932 |
| 1:173635611:G:C | W30C | 0.926 |
| 1:173635611:G:T | W30C | 0.926 |
| 1:173635626:G:C | W35C | 0.908 |
| 1:173635626:G:T | W35C | 0.908 |
| 1:173635631:T:C | I37T | 0.875 |
| 1:173635622:G:A | G34E | 0.845 |
| 1:173635621:G:A | G34R | 0.840 |
| 1:173635621:G:C | G34R | 0.840 |
| 1:173635624:T:A | W35R | 0.839 |
| 1:173635624:T:C | W35R | 0.839 |
| 1:173635628:A:T | E36V | 0.815 |
| 1:173635631:T:G | I37S | 0.814 |
| 1:173635617:G:C | K32N | 0.790 |
| 1:173635617:G:T | K32N | 0.790 |
| 1:173635827:G:C | W102C | 0.788 |
| 1:173635827:G:T | W102C | 0.788 |
| 1:173635814:T:C | L98P | 0.758 |
| 1:173635610:G:C | W30S | 0.752 |
| 1:173635816:T:A | W99R | 0.751 |
| 1:173635816:T:C | W99R | 0.751 |
| 1:173635825:T:A | W102R | 0.724 |
| 1:173635825:T:C | W102R | 0.724 |
| 1:173635634:T:C | L38P | 0.717 |
| 1:173635619:T:A | V33D | 0.711 |
| 1:173635636:C:T | P39S | 0.710 |
| 1:173635627:G:A | E36K | 0.700 |
| 1:173635618:G:C | V33L | 0.694 |
| 1:173635636:C:A | P39T | 0.691 |
dbSNP variants (sampled 300 via entrez): RS1000003492 (1:173634713 A>G), RS1000269357 (1:173637181 G>A), RS1001005380 (1:173635213 T>G), RS1001075774 (1:173634861 C>A), RS1002009575 (1:173633995 T>C), RS1002427863 (1:173635958 C>A), RS1006087310 (1:173636885 A>G), RS1006697132 (1:173637288 A>C,G,T), RS1007594428 (1:173636425 C>A), RS1007796663 (1:173636723 T>C), RS1008481877 (1:173633515 C>T), RS1008814094 (1:173634957 A>G), RS1014139379 (1:173635638 A>C,G), RS1014352645 (1:173635530 T>A,C), RS1014382408 (1:173635931 C>T)
Disease associations
OMIM: gene MIM:621346 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression, affects cotreatment | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Lipopolysaccharides | increases expression, affects cotreatment, affects response to substance | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.